Fitmore Hip Stem PMCF Study: A Multi-centre, Non-comparative, Prospective Post-market Clinical Follow-up Study.

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

420 participants

Study Classification

OBSERVATIONAL

Study Start Date

2008-02-08

Study Completion Date

2023-06-10

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

A multi-centre, non-comparative, prospective post-market clinical follow-up study to obtain survival, clinical and radiographic outcomes data on the Zimmer Fitmore Hip Stem.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Clinical Outcome Following Total Hip Arthroplasty With the SMF Stem

NCT02471703

Joint Diseases

TERMINATED

Z1 Hip System: Post-Market Clinical Follow Up Study

NCT07104279

Hip Osteoarthritis Acute Traumatic Fracture of the Femoral Head or Neck Avascular Necrosis of the Femoral Head

RECRUITING

PMCF Study on the Safety and Performance of the Zimmer® Maxera™ Acetabular System in Total Hip Arthroplasty

NCT03372278

Rheumatoid Arthritis With Adequate Bone Quality Inflammatory Arthritis Osteoarthritis, Hip +3 more

ACTIVE_NOT_RECRUITING

Avenir® Cemented Hip Stem - PMCF

NCT03396224

Primary Osteoarthritis Post-Traumatic Osteoarthritis of Hip Femoral Neck Fractures +4 more

ACTIVE_NOT_RECRUITING

An MRI Investigation of Soft Tissues in Total Hip Arthroplasty

NCT01750606

Tissue Reaction Elevated Blood Ion Levels

UNKNOWN

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The objective of this post market surveillance study is to obtain outcome data on the Fitmore Hip Stem by analysis of standard scoring systems, radiographs and adverse event records, and thus to assess the long-term performance and safety of this implant.

The Fitmore Hip Stem is a short and curved uncemented stem that allows preservation of the greater trochanter and of the gluteal muscles.

Indication/Target Population: Patients suffering from severe hip pain and disability requiring total hip arthroplasty.

Study Design: A multi-centre, non-comparative, prospective post-marketing study.

Targeted Number of Subjects: 500. Data Collection: Collection of preoperative, intra-operative and immediate post-operative data; follow-up visits at 6-12 weeks, 1, 2, 3, 5, 7 and 10 years post-operatively.

Recruitment period: 24 months. Clinical Assessments: Evaluations will be made using the Harris Hip Score, the Oxford Hip Score, the SF-12 Physical and Mental Health summary measures, the EQ-5D (EuroQol) and radiographically.

Safety Assessments: Safety will be assessed by appropriate recording and reporting of adverse events throughout the study. The Fitmore Hip Stem is CE marked, commercially available and has been pre-clinically tested.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Osteoarthritis Avascular Necrosis Rheumatoid Arthritis Prosthesis Failure

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Subjects with a Fitmore Hip Stem

Subjects in need of a total hip arthroplasty who met the inclusion/exclusion criteria and who received the Fitmore Hip Stem.

Fitmore Hip Stem

Intervention Type DEVICE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Fitmore Hip Stem

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients who are capable of understanding the doctor"s explanations, following his instructions and who are able to participate in the follow-up program.
* Patients who have given written consent to take part in the study by signing the "Patient Consent Form".
* 18 years minimum.
* Male and female.
* Patients suffering from severe hip pain and disability requiring hip surgery or as indicated in the treatment of a fracture.